New catheter device shows promise for treating dangerous lung clots
NCT ID NCT06571760
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new device called the Vertex Pulmonary Embolectomy System in 10 people with pulmonary embolism (blood clots in the lungs). The device is threaded through a blood vessel to remove clots and relieve strain on the right side of the heart. Researchers measured changes in heart chamber size and tracked any serious side effects within 48 hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vertex Pulmonary Embolectomy System (a catheter device to remove blood clots from lung arteries)
What this could lead to
If successful, this device could offer a new way to quickly reduce heart strain in people with severe pulmonary embolism, potentially preventing long-term heart damage.
What could go wrong
This was a very small, early study with only 10 participants and no comparison group, so results may not apply to everyone. Risks include bleeding, vessel injury, or device-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AKH Vienna - Medical university of Vienna
Vienna, 1090, Austria
-
Jagiellonian University
Krakow, Poland